Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neonatal pharmacology and clinical implications. | Drugs Context | 2019 | 31692800 | PubTator, text mining | PubMed |
| [PHENOTYPIC POLYMORPHISM OF N-ACETYLTRANSFERASE 2 IN PATIENTS WITH DIABETES MELLITUS]. | Georgian Med News | 2019 | 31687957 | PubTator, text mining | PubMed |
| Polypharmacy: a healthcare conundrum with a pharmacogenetic solution. | Crit Rev Clin Lab Sci | 2019 | 31680605 | PubTator, text mining | PubMed |
| Associations Between Glutathione-S-Transferase Genotypes and Bronchial Hyperreactivity Patients With Di-isocyanate Induced Asthma. A Follow-Up Study. | Front Med (Lausanne) | 2019 | 31649932 | PubTator, text mining | PubMed |
| Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico. | Front Pharmacol | 2019 | 31649539 | PubTator, text mining | PubMed |
| The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer. | BMC Cancer | 2019 | 31646988 | PubTator, text mining | PubMed |
| Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology. | Bone Res | 2019 | 31646017 | PubTator, text mining | PubMed |
| 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells. | Cancers (Basel) | 2019 | 31614463 | PubTator, text mining | PubMed |
| DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. | Clin Epigenetics | 2019 | 31601247 | PubTator, text mining | PubMed |
| Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. | N Engl J Med | 2019 | 31577875 | PubTator, text mining | PubMed |
| Recent progress regarding kaempferol for the treatment of various diseases. | Exp Ther Med | 2019 | 31572524 | PubTator, text mining | PubMed |
| Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson's Disease. | Planta Med | 2019 | 31559607 | PubTator, text mining | PubMed |
| Isolation, analysis and in vitro assessment of CYP3A4 inhibition by methylxanthines extracted from Pu-erh and Bancha tea leaves. | Sci Rep | 2019 | 31558747 | PubTator, text mining | PubMed |
| A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells. | Front Pharmacol | 2019 | 31551763 | PubTator, text mining | PubMed |
| Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing. | Arch Toxicol | 2019 | 31542801 | PubTator, text mining | PubMed |
| The Variant at TGFBRAP1 but Not TGFBR2 Is Associated with Antituberculosis Drug-Induced Liver Injury. | Evid Based Complement Alternat Med | 2019 | 31534460 | PubTator, text mining | PubMed |
| Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3. | J Immunother Cancer | 2019 | 31533831 | PubTator, text mining | PubMed |
| N-Acetyltransferase 1 Knockout Elevates Acetyl Coenzyme A Levels and Reduces Anchorage-Independent Growth in Human Breast Cancer Cell Lines. | J Oncol | 2019 | 31531019 | PubTator, text mining | PubMed |
| Biology of Inherited Cataracts and Opportunities for Treatment. | Annu Rev Vis Sci | 2019 | 31525139 | PubTator, text mining | PubMed |
| Genetic Variant of NFIB is Associated With the Metastasis of Osteosarcoma in Chinese Population. | Technol Cancer Res Treat | 2019 | 31522615 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=48